2002
DOI: 10.1016/s0149-2918(02)80065-0
|View full text |Cite
|
Sign up to set email alerts
|

Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
28
0
1

Year Published

2004
2004
2009
2009

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(34 citation statements)
references
References 18 publications
2
28
0
1
Order By: Relevance
“…In the study by Schaefer et al [9] from Germany, four groups were treated and different dropout rates were observed: 13% in controls, 18% in patients with psychiatric disorders, 14% in patients with a history of opioid addiction on methadone maintenance therapy and 43% in former drug addicts without maintenance therapy. In a study by Neri et al [11] from Italy, a dropout rate of 36% in former heroin users compared to none in the control group was reported. In another study from Germany, Mauss et al [12] found a dropout rate of 22% compared with 4% in the control group within the first 8 weeks of therapy.…”
Section: Introductionmentioning
confidence: 95%
“…In the study by Schaefer et al [9] from Germany, four groups were treated and different dropout rates were observed: 13% in controls, 18% in patients with psychiatric disorders, 14% in patients with a history of opioid addiction on methadone maintenance therapy and 43% in former drug addicts without maintenance therapy. In a study by Neri et al [11] from Italy, a dropout rate of 36% in former heroin users compared to none in the control group was reported. In another study from Germany, Mauss et al [12] found a dropout rate of 22% compared with 4% in the control group within the first 8 weeks of therapy.…”
Section: Introductionmentioning
confidence: 95%
“…126,127 An Italian study of newly detoxified heroin users (within 2-4 weeks of detoxification treatment) found an enhanced response to interferon alfa-n2b treatment (8 weeks of treatment) for the user group in comparison to controls without a history of drug addiction, although there were no data on sustained virological response. 128 An evaluation study of the safety, tolerability, and efficacy of interferon/ribavirin combination therapy in HCV-infected illicit opiate injector patients engaged in methadone maintenance treatment found that the end-of-treatment response rate was similar to that of patients without a history of illicit drug use. 129 Researchers in Munich conducted a study of treatment with interferon alfa plus ribavirin for psychiatric risk groups (n = 81), including psychiatric patients, methadone treatment clients, patients with former addictions, and a control group.…”
Section: New Hepatitis C Virus Treatment: the Chance For Hepatitis C mentioning
confidence: 99%
“…Opioids, especially heroin and morphine, can produce severe changes in the immune system and can possess a two-step action in the production of cytokines with phases of stimulation and inhibition (Kreek 1996;Pacifici et al 2000;Neri et al 2002). It was demonstrated in some studies that long-term methadone treatment can progressively restore the immune system and increase cytokine production (Kreek 1996;Pacifici et al 2000;Neri et al 2002).…”
Section: Introductionmentioning
confidence: 99%
“…It was demonstrated in some studies that long-term methadone treatment can progressively restore the immune system and increase cytokine production (Kreek 1996;Pacifici et al 2000;Neri et al 2002).…”
Section: Introductionmentioning
confidence: 99%